Education
About Us
Working with TipRanks
Follow Us
Utah Medical Products (UTMD)
:UTMD
Total Valuation
Utah Medical Products has a market cap or net worth of $184.63M. The enterprise value is $102.84M.
Market Cap$184.63M
Enterprise Value$102.84M
Share Statistics
Utah Medical Products has 3,248,210 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,248,210
Owned by Insiders0.03%
Owned by Institutions0.70%
Financial Efficiency
Utah Medical Products’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 9.45%.
Return on Equity (ROE)0.12
Return on Assets (ROA)0.11
Return on Invested Capital (ROIC)9.45%
Return on Capital Employed (ROCE)0.11
Revenue Per Employee263.89K
Profits Per Employee89.51K
Employee Count155
Asset Turnover0.33
Inventory Turnover1.90
Valuation Ratios
The current PE Ratio of Utah Medical Products is 15.2. Utah Medical Products’s PEG ratio is ―.
PE Ratio15.2
PS Ratio0.00
PB Ratio0.00
Price to Fair Value1.83
Price to FCF0.00
Price to Operating Cash Flow13.98
PEG Ratio―
Income Statement
In the last 12 months, Utah Medical Products had revenue of 40.90M and earned 13.87M in profits. Earnings per share was 3.96.
Revenue40.90M
Gross Profit24.14M
Operating Income13.59M
Pretax Income16.80M
Net Income13.87M
EBITDA16.44M
Earnings Per Share (EPS)3.96
Cash Flow
In the last 12 months, operating cash flow was 14.42M and capital expenditures -385.00K, giving a free cash flow of 14.04M billion.
Operating Cash Flow14.42M
Free Cash Flow14.04M
Free Cash Flow per Share4.32
Dividends & Yields
Utah Medical Products pays an annual dividend of $0.305, resulting in a dividend yield of 2.21%
Dividend Per Share$0.305
Dividend Yield2.21%
Payout Ratio32.50%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.53
52-Week Price Change-12.09%
50-Day Moving Average56.10
200-Day Moving Average58.50
Relative Strength Index (RSI)52.11
Average Volume (3m)15.37K
Important Dates
Utah Medical Products upcoming earnings date is Oct 28, 2025, TBA (Confirmed).
Last Earnings DateJul 24, 2025
Next Earnings DateOct 28, 2025
Ex-Dividend DateSep 17, 2025
Financial Position
Utah Medical Products as a current ratio of 25.64, with Debt / Equity ratio of 0.22%
Current Ratio25.64
Quick Ratio23.29
Debt to Market Cap0.00
Net Debt to EBITDA-5.03
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Utah Medical Products has paid 2.93M in taxes.
Income Tax2.93M
Effective Tax Rate0.17
Enterprise Valuation
Utah Medical Products EV to EBITDA ratio is 8.07, with an EV/FCF ratio of 9.09.
EV to Sales3.24
EV to EBITDA8.07
EV to Free Cash Flow9.09
EV to Operating Cash Flow8.94
Balance Sheet
Utah Medical Products has $83.33M in cash and marketable securities with $269.00K in debt, giving a net cash position of -$83.06M billion.
Cash & Marketable Securities$83.33M
Total Debt$269.00K
Net Cash-$83.06M
Net Cash Per Share-$25.57
Tangible Book Value Per Share$28.83
Margins
Gross margin is 55.94%, with operating margin of 33.23%, and net profit margin of 33.92%.
Gross Margin55.94%
Operating Margin33.23%
Pretax Margin41.08%
Net Profit Margin33.92%
EBITDA Margin40.19%
EBIT Margin33.23%
Analyst Forecast
The average price target for Utah Medical Products is $64.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$64.00
Price Target Upside12.60% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast-16.64%
EPS Growth Forecast―